$GNPX
Genprex Inc

2019 Q1 Form 10-K Financial Statement

#000156459019010279 Filed on April 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.660M $11.39M $600.0K
YoY Change 163.49% 277.15% -31.03%
% of Gross Profit
Research & Development $508.0K $971.4K $60.00K
YoY Change 884.18% 235.05% -53.85%
% of Gross Profit
Depreciation & Amortization $2.931K $5.885K $0.00
YoY Change 209.5% 81.52%
% of Gross Profit
Operating Expenses $508.0K $971.4K $660.0K
YoY Change 884.18% 235.05% -34.0%
Operating Profit -$2.171M -$12.36M
YoY Change 216.15% 273.26%
Interest Expense $0.00 $37.98K $0.00
YoY Change -100.0% 1909.63%
% of Operating Profit
Other Income/Expense, Net -$8.798K
YoY Change 386.08%
Pretax Income -$2.160M -$12.37M -$670.0K
YoY Change 213.04% 273.72% -33.0%
Income Tax
% Of Pretax Income
Net Earnings -$2.159M -$12.37M -$670.0K
YoY Change 211.07% 273.32% -33.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$140.8K -$898.3K -$51.38K
COMMON SHARES
Basic Shares Outstanding 15.54M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.950M $8.600M $160.0K
YoY Change 34650.0% 5275.0% -90.0%
Cash & Equivalents $6.946M $161.3K
Short-Term Investments
Other Short-Term Assets $100.0K $240.0K $20.00K
YoY Change 233.33% 1100.0% -50.0%
Inventory
Prepaid Expenses
Receivables $0.00 $10.00K $10.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.050M $8.850M $193.6K
YoY Change 11972.54% 4557.89% -88.19%
LONG-TERM ASSETS
Property, Plant & Equipment $30.00K $20.00K $7.804K
YoY Change 260.32% 100.0% 51.33%
Goodwill
YoY Change
Intangibles $388.7K $298.6K
YoY Change 26.38% 23.87%
Long-Term Investments
YoY Change
Other Assets $404.8K $20.00K $1.058M
YoY Change -69.32% -97.37% 296.99%
Total Long-Term Assets $426.4K $420.0K $1.066M
YoY Change -67.89% -60.75% 292.33%
TOTAL ASSETS
Total Short-Term Assets $7.050M $8.850M $193.6K
Total Long-Term Assets $426.4K $420.0K $1.066M
Total Assets $7.476M $9.270M $1.260M
YoY Change 439.27% 635.71% -34.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $210.0K $300.0K $630.0K
YoY Change -81.74% -52.38% 117.24%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $20.00K $90.00K $200.0K
YoY Change -92.86% -55.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $231.1K $390.0K $831.0K
YoY Change -83.82% -53.01% 190.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $231.1K $390.0K $831.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $230.0K $390.0K $830.0K
YoY Change -83.92% -53.01% 186.21%
SHAREHOLDERS EQUITY
Retained Earnings -$31.98M -$17.45M
YoY Change 76.25% 23.44%
Common Stock $15.56K $11.72K
YoY Change 32.39% 3.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.245M $8.880M $428.6K
YoY Change
Total Liabilities & Shareholders Equity $7.476M $9.270M $1.260M
YoY Change 439.27% 635.71% -34.07%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$2.159M -$12.37M -$670.0K
YoY Change 211.07% 273.32% -33.0%
Depreciation, Depletion And Amortization $2.931K $5.885K $0.00
YoY Change 209.5% 81.52%
Cash From Operating Activities -$1.642M -$6.847M -$210.0K
YoY Change 705.94% 215.28% -75.29%
INVESTING ACTIVITIES
Capital Expenditures $4.111K $22.44K $0.00
YoY Change 179.85% 280.96% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.33K -$103.3K $0.00
YoY Change 27.54% 62.91% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $15.39M
YoY Change 1838.3%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.39M 0.000
YoY Change 1838.3% -100.0%
NET CHANGE
Cash From Operating Activities -1.642M -6.847M -210.0K
Cash From Investing Activities -13.33K -103.3K 0.000
Cash From Financing Activities 15.39M 0.000
Net Change In Cash -1.655M 8.440M -210.0K
YoY Change 1110.19% -685.66% -133.33%
FREE CASH FLOW
Cash From Operating Activities -$1.642M -$6.847M -$210.0K
Capital Expenditures $4.111K $22.44K $0.00
Free Cash Flow -$1.646M -$6.869M -$210.0K
YoY Change 702.17% 215.45% -74.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15536765
CY2018Q2 dei Entity Public Float
EntityPublicFloat
30400000
CY2018Q4 us-gaap Cash
Cash
8600918
CY2017Q4 us-gaap Cash
Cash
161251
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9297
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8844
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236851
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23479
CY2018Q4 us-gaap Assets Current
AssetsCurrent
8847066
CY2017Q4 us-gaap Assets Current
AssetsCurrent
193574
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24354
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7804
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
759591
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18085
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
379451
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
298569
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
397536
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1058160
CY2018Q4 us-gaap Assets
Assets
9268956
CY2017Q4 us-gaap Assets
Assets
1259538
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
295069
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
629074
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
92752
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
201890
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
387821
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
830964
CY2018Q4 gnpx Investment Unit
InvestmentUnit
0
CY2017Q4 gnpx Investment Unit
InvestmentUnit
0
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
15240
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11721
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38690586
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17869205
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29824691
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17452352
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8881135
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9268956
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259538
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15239148
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11721584
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15239148
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11721584
CY2017 us-gaap Revenues
Revenues
0
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
12363541
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
3312347
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-12363541
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-3312347
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
29184
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
80
CY2018 us-gaap Interest Expense
InterestExpense
37982
CY2017 us-gaap Interest Expense
InterestExpense
1890
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8798
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1810
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-12372339
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-3314157
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13771020
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11500032
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1624868
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
793971
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1095230
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
228662
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15389518
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
553303
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4882079
CY2018 us-gaap Profit Loss
ProfitLoss
-12372339
CY2017 us-gaap Profit Loss
ProfitLoss
-3314157
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
5435382
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1323892
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
453
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
663
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
213372
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4873
CY2018 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-18085
CY2017 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
0
CY2018 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-759591
CY2017 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
734084
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-443143
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
545303
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6846534
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2171594
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22435
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5889
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
80882
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
57532
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103317
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63421
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15389518
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
793971
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15389518
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
793971
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8439667
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1441044
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161251
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1602295
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600918
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
8465768
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2018 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
CY2018Q4 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2018Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018Q4 gnpx Number Of Patents
NumberOfPatents
32
CY2018 gnpx Number Of Allowed Patents
NumberOfAllowedPatents
1
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2018Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
CY2018 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-08-13
CY2018 us-gaap Debt Instrument Description
DebtInstrumentDescription
If no event of default occurs prior to August 13, 2020, the Promissory Note and all related interest will be cancelled.
CY2018 gnpx Warrant Right To Purchase Percentage
WarrantRightToPurchasePercentage
0.80
CY2018 gnpx Warrant Discount Rate
WarrantDiscountRate
0.20
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 gnpx Conversion Of Stock Shares Issued And Forward Stock Split
ConversionOfStockSharesIssuedAndForwardStockSplit
1235219
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2018Q2 gnpx Warrant To Purchase Shares Of Common Stock
WarrantToPurchaseSharesOfCommonStock
38400
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200009
CY2017 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
207206
CY2017Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
150211
CY2018Q2 gnpx Non Voting Common Stock Conversion Ratio
NonVotingCommonStockConversionRatio
1
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4535681
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M2D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M23D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2034525
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
127593
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.21
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2017Q4 gnpx Percentage Applied On Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageAppliedOnOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9600000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31

Files In Submission

Name View Source Status
0001564590-19-010279-index-headers.html Edgar Link pending
0001564590-19-010279-index.html Edgar Link pending
0001564590-19-010279.txt Edgar Link pending
0001564590-19-010279-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnpx-10k_20181231.htm Edgar Link pending
gnpx-20181231.xml Edgar Link completed
gnpx-20181231.xsd Edgar Link pending
gnpx-20181231_cal.xml Edgar Link unprocessable
gnpx-20181231_def.xml Edgar Link unprocessable
gnpx-20181231_lab.xml Edgar Link unprocessable
gnpx-20181231_pre.xml Edgar Link unprocessable
gnpx-ex231_562.htm Edgar Link pending
gnpx-ex311_12.htm Edgar Link pending
gnpx-ex312_8.htm Edgar Link pending
gnpx-ex321_6.htm Edgar Link pending
gylze0pdymuz000001.jpg Edgar Link pending
gylze0pdymuz000002.jpg Edgar Link pending
gylze0pdymuz000003.jpg Edgar Link pending
gylze0pdymuz000004.jpg Edgar Link pending
gylze0pdymuz000005.jpg Edgar Link pending
gylze0pdymuz000006.jpg Edgar Link pending
gylze0pdymuz000007.jpg Edgar Link pending
gylze0pdymuz000008.jpg Edgar Link pending
gylze0pdymuz000009.jpg Edgar Link pending
gylze0pdymuz000010.jpg Edgar Link pending
gylze0pdymuz000011.jpg Edgar Link pending
gylze0pdymuz000012.jpg Edgar Link pending
gylze0pdymuz000013.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending